Skip to main content
38°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
3 Personalized Medicine Stocks to Buy for Long-Time Returns
May 15, 2023
Tickers
ADPT
EXAS
GSK
ME
Tags
EXAS
ADPT
NASDAQ:EXAS,NYSE:GSK,NASDAQ:ADPT,OCTMKTS:RHHBY,NASDAQ:ME
From
InvestorPlace
EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
May 04, 2023
Tickers
RHHBY
SABS
Tags
Benzinga
Health Care
SABS
From
Benzinga
Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study: Analysts Get Bullish
April 28, 2023
Tickers
RHHBY
TPST
Tags
Analyst Ratings
Movers
RHHBY
From
Benzinga
Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline
April 26, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
Benzinga
Health Care
From
Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
April 26, 2023
Tickers
REGN
RHHBY
SABS
Tags
Penny Stocks
Market News
Exclusives
From
Benzinga
3 Top Biotech Stocks Defying the Bear Market
April 25, 2023
Tickers
BGNE
BIIB
LLY
NVS
Tags
BGNE
BIIB
NVS
From
Motley Fool
This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health
April 25, 2023
Tickers
ABT
DXCM
RHHBY
TECH
Tags
Tech
Market News
General
From
Benzinga
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
April 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
RHHVF
From
Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
April 13, 2023
Tickers
RHHBF
RHHBY
RHHVF
SABS
Tags
FDA Fast Track
Benzinga
Health Care
From
Benzinga
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
April 11, 2023
Tickers
ADAP
GSK
RHHBY
Tags
GSK
RHHBY
ADAP
From
Motley Fool
Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies
March 30, 2023
Tickers
BMY
BOLT
RHHBY
Tags
Penny Stocks
Market News
Biotech
From
Benzinga
Roche's Slow Growth Shouldn't Drive Investors Away
March 28, 2023
Tickers
RHHBY
Tags
RHHBY
Market News
Recent Press Releases
From
Motley Fool
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
March 22, 2023
Tickers
LLY
RHHBY
Tags
News
LLY
Eurasia
From
Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
March 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Benzinga
Eurasia
From
Benzinga
Is Roche a Buy Now?
March 20, 2023
Tickers
RHHBY
Tags
RHHBY
Market News
Recent Press Releases
From
Motley Fool
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
March 17, 2023
Tickers
RHHBY
SRPT
Tags
Benzinga
why it's moving
Health Care
From
Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
March 09, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
RHHBF
Briefs
From
Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
Tickers
APVO
BEAM
CMRX
DVAX
Tags
CMRX
BEAM
VIR
From
InvestorPlace
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
March 03, 2023
Tickers
EXEL
RHHBF
RHHBY
RHHVF
Tags
Biotech
RHHBF
Briefs
From
Benzinga
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
March 02, 2023
Tickers
RHHBY
SRPT
Tags
RHHBY
Market News
Recent Press Releases
From
Motley Fool
3 Best Growth Stocks to Buy In March
March 02, 2023
Tickers
HIMS
IWF
MELI
RHHBY
Tags
SRPT
RHHBY
Market News
From
Motley Fool
Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients
February 27, 2023
Tickers
BPMC
RHHBY
Tags
RHHBY
General
Market News
From
Benzinga
Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines
February 23, 2023
Tickers
BPMC
RHHBF
RHHBY
RHHVF
Tags
News
Contracts
BPMC
From
Benzinga
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
February 23, 2023
Tickers
ABBV
INFI
MEIP
MRK
Tags
Penny Stocks
Market News
Biotech
From
Benzinga
New Data Shows Roche's Vabysmo Improves Vision, Retinal Fluid In Retinal Disorder
February 10, 2023
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Biotech
Briefs
RHHBF
From
Benzinga
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
February 07, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
General
RHHBY
From
Benzinga
Roche Flags Lower 2023 Sales On Declining Demand For COVID-19 Treatment, Diagnostics
February 02, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Guidance
Benzinga
Health Care
From
Benzinga
Roche Introduces Test To Detect Contagious XBB.1.5 Omicron Sub-Variant
January 26, 2023
Tickers
RHHBF
RHHBY
Tags
Market News
RHHBY
Briefs
From
Benzinga
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
January 19, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Large Cap
RHHVF
General
From
Benzinga
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
January 17, 2023
Tickers
AERG
ATLX
CLNV
CYDY
Tags
HEINY
Benzinga
CLNV
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.